Providing Rapid Pathogen Identification for Bloodstream Infections
The AdvanDx FISH product lines offer early pathogen identification for patients with bloodstream infections. Through rapid diagnostics and better clinical information, we’ve set out to help clinicians and laboratories provide better patient management.
The AdvanDx FISH product lines offer molecular testing of positive blood cultures enabling clinical microbiology labs to report pathogen identification results 48 to 72 hours earlier than conventional testing methods. The AdvanDx PNA FISH® and QuickFISH® tests can help reduce turn-around time to pathogen identification, shorten length of stay (LOS) and lower hospital costs.1,2
About Our Technology
AdvanDx employs a unique, Whole Cell Analysis (WCA) approach to pathogen identification using our proprietary Peptide Nucleic Acid Fluorescence in Situ Hybridization (PNA FISH) technology platform. This technology enables fast and highly accurate single cell analysis for species, resistance and virulence marker identification of bacterial and fungal cells found in samples from patients with critical infections.